Surgalign Holdings, Inc. (SRGA)

NASDAQ: SRGA · IEX Real-Time Price · USD
1.75
+0.09 (5.42%)
Mar 31, 2023, 12:25 PM EDT - Market open
5.42%
Market Cap 22.07M
Revenue (ttm) 83.24M
Net Income (ttm) -60.86M
Shares Out 12.76M
EPS (ttm) -13.12
PE Ratio n/a
Forward PE 526.32
Dividend n/a
Ex-Dividend Date n/a
Volume 82,252
Open 1.64
Previous Close 1.66
Day's Range 1.61 - 1.80
52-Week Range 1.34 - 9.30
Beta 1.78
Analysts Buy
Price Target 4.34 (+148.0%)
Earnings Date May 9, 2023

About SRGA

Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical p... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1997
Employees 231
Stock Exchange NASDAQ
Ticker Symbol SRGA
Full Company Profile

Financial Performance

In 2021, SRGA's revenue was $90.50 million, a decrease of -11.06% compared to the previous year's $101.75 million. Losses were -$84.65 million, 150.6% more than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for SRGA stock is "Buy." The 12-month stock price forecast is $4.34, which is an increase of 148.00% from the latest price.

Price Target
$4.34
(148.00% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results

DEERFIELD, Ill., March 30, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of d...

20 hours ago - GlobeNewsWire

Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023

DEERFIELD, Ill., March 21, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of d...

1 week ago - GlobeNewsWire

Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023

DEERFIELD, Ill., March 16, 2023 (GLOBE NEWSWIRE) --  Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of ...

2 weeks ago - GlobeNewsWire

Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance

Company on track to achieve target cash savings of $30 - $35 million in 2023 vs 2022; expects to report 2022 revenue of approximately $82.0 million and end the year with a cash balance in excess of $1...

3 weeks ago - GlobeNewsWire

Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in Las Vegas

Dr. Rick C. Sasso, renowned spinal surgeon to highlight Surgalign's HOLO Portal™ Surgical Guidance System on the OrthoDome Panel on March 8, 2023 Dr. Rick C. Sasso, renowned spinal surgeon to highligh...

1 month ago - GlobeNewsWire

Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million

Expands Xtant's Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device

1 month ago - GlobeNewsWire

Surgalign Announces 100th Case Completed Utilizing its Recently Launched Cortera™ Spinal Fixation System

DEERFIELD, Ill., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of di...

3 months ago - GlobeNewsWire

Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

DEERFIELD, Ill., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of di...

4 months ago - GlobeNewsWire

Surgalign™ Announces Corporate Restructuring Program to Focus on Key Growth Areas

Company plans to realign in an effort to improve efficiencies, while lowering its capital requirements to invest in innovation; estimated cash savings in 2023 are expected to be approximately $30 - $3...

5 months ago - GlobeNewsWire

Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook

DEERFIELD, Ill., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

5 months ago - GlobeNewsWire

Surgalign Schedules Third Quarter 2022 Earnings Release for November 2, 2022

DEERFIELD, Ill., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

5 months ago - GlobeNewsWire

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

DEERFIELD, Ill., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of di...

6 months ago - GlobeNewsWire

Surgalign Launches Portfolio of Fortilink® with TiPlus™ Technology Products, Expanding its Addressable Market for Interbody Fusion Procedures

Broadens Fortilink interbody product line to now include both titanium and 3D-printed polymer options Broadens Fortilink interbody product line to now include both titanium and 3D-printed polymer opti...

6 months ago - GlobeNewsWire

Surgalign to Exhibit at the Society for Minimally Invasive Spine Surgery (“SMISS”) Annual Forum and the North American Spine Society (“NASS”) 2022 Annual Meeting

Company to showcase its HOLO Portal™ surgical guidance system for the first time at an industry event, with live, hands-on demonstrations from surgeons and medical professionals Company to showcase it...

7 months ago - GlobeNewsWire

Surgalign Announces FDA 510(k) Clearance of the Cortera™ Spinal Fixation System – The Company's New Flagship Posterior Fixation Platform

DEERFIELD, Ill., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

7 months ago - GlobeNewsWire

Surgalign Announces Global Settlement Agreement with Resolve Surgical Technologies and RTI Surgical, Inc.

Parties enter into new sole-source supply relationship, extended for two years Parties enter into new sole-source supply relationship, extended for two years

8 months ago - GlobeNewsWire

Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance Range

DEERFIELD, Ill., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

8 months ago - GlobeNewsWire

Surgalign Names Paolo Amoruso Chief Legal Officer and Corporate Secretary

DEERFIELD, Ill., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

8 months ago - GlobeNewsWire

Surgalign Reaches Settlement with the Securities and Exchange Commission on Matters Related to Prior Management Between 2015-2019

DEERFIELD, Ill., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) on August 3, 2022, concluding ...

8 months ago - GlobeNewsWire

Surgalign Announces the Commercial Relaunch of its Next Generation CervAlign Anterior Cervical Plate System Optimized for Discectomy and Fusion Procedures

DEERFIELD, Ill., July 20, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of di...

9 months ago - GlobeNewsWire

Surgalign Announces Partnership with PRIA Healthcare to Improve Patient Healthcare Coverage

Program to aid in patient access to Surgalign's Coflex® Interlaminar Stabilization® and SImmetry® SI Joint Fusion Systems

9 months ago - GlobeNewsWire

Here's Why Surgalign Holdings Shares Are Falling Today

Surgalign Holdings Inc (NASDAQ: SRGA) shares are trading lower by 19.73% at $0.15 after the company announced a 1-for-30 reverse stock split. The 1-for-30 reverse stock split will take effect at the o...

11 months ago - Benzinga

Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split

DEERFIELD, Ill., May 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of dig...

11 months ago - GlobeNewsWire

Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range

DEERFIELD, Ill., May 10, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of dig...

11 months ago - GlobeNewsWire

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

DEERFIELD, Ill., May 06, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of dig...

11 months ago - GlobeNewsWire